药物类阿片滥用阻止制剂的效果和框架。
Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations.
机构信息
National Drug and Alcohol Research Centre, University of New South Wales Sydney, NSW, Australia.
School of Psychology, University of Wollongong, NSW, Australia.
出版信息
Addiction. 2019 Mar;114(3):404-405. doi: 10.1111/add.14556.
Abstract
Abuse-deterrent formulations (ADFs) of pharmaceutical opioids have limited capacity to reduce extra-medical use and harm; their impact is likely restricted to prevention of specific practices among population sub-groups. This debate highlights the importance of viewing ADFs as one component in a range of public health responses. Greater involvement of invested parties (e.g., prescribers, consumers) and reframing terminology will reduce discrimination and stigma.
摘要
药物阿片类药物的滥用阻止配方（ADFs）减少了非医疗使用和伤害的能力有限；它们的影响可能仅限于预防人群亚群中的特定行为。这场辩论强调了将 ADF 视为一系列公共卫生应对措施的一个组成部分的重要性。更多利益相关方（例如，处方者、消费者）的参与和重新调整术语将减少歧视和污名化。
相似文献
1
Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations.药物类阿片滥用阻止制剂的效果和框架。
Addiction. 2019 Mar;114(3):404-405. doi: 10.1111/add.14556.
2
Morphine sulfate abuse-deterrent formulations for the treatment of chronic pain.硫酸吗啡滥用防御制剂治疗慢性疼痛。
Expert Rev Clin Pharmacol. 2018 Dec;11(12):1157-1162. doi: 10.1080/17512433.2018.1545573. Epub 2018 Nov 17.
3
Prevention of Opioid Abuse and Treatment of Opioid Addiction: Current Status and Future Possibilities.预防阿片类药物滥用和治疗阿片类药物成瘾：现状和未来可能。
Annu Rev Biomed Eng. 2019 Jun 4;21:61-84. doi: 10.1146/annurev-bioeng-060418-052155. Epub 2019 Feb 20.
4
Current Impact and Application of Abuse-Deterrent Opioid Formulations in Clinical Practice.滥用防御阿片类药物制剂在临床实践中的当前影响和应用。
Pain Physician. 2017 Nov;20(7):E1003-E1023.
5
Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.阿片类药物滥用预防制剂对美国慢性疼痛患者的影响：成本效益模型。
Value Health. 2019 Apr;22(4):416-422. doi: 10.1016/j.jval.2018.12.005. Epub 2019 Mar 21.
6
Opioids with abuse-deterrent properties: A regulatory and technological overview.具有滥用威慑特性的阿片类药物：监管与技术概述。
J Opioid Manag. 2017 Nov/Dec;13(6):397-413. doi: 10.5055/jom.2017.0417.
7
Abuse-deterrent and tamper-resistant opioids: how valuable are novel formulations in thwarting non-medical use?滥用防御和篡改防范类阿片类药物：新型制剂在阻止非医疗用途方面有多大价值？
Expert Opin Drug Deliv. 2013 Feb;10(2):229-40. doi: 10.1517/17425247.2013.751095. Epub 2012 Dec 20.
8
Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.评估奥施康定（oxycodone）改良版对阿片类药物篡改、不遵医嘱和滥用的潜在影响：国家阿片类药物滥用预防（NOMAD）研究方案。
Addiction. 2015 Feb;110(2):226-37. doi: 10.1111/add.12746. Epub 2014 Oct 30.
9
Evaluating dynamic impacts of abuse-deterrent prescription opioid formulations.评估阿片类处方镇痛药滥用威慑剂型的动态影响。
Addiction. 2019 Mar;114(3):400-401. doi: 10.1111/add.14454. Epub 2018 Oct 31.
10
Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?滥用防范阿片类药物制剂：预防阿片灾难的关键因素？
Clin Drug Investig. 2018 Jul;38(7):573-577. doi: 10.1007/s40261-018-0651-3.
本文引用的文献
1
Are abuse-deterrent opioid formulations all they are crushed up to be?具有滥用威慑作用的阿片类药物制剂真的如人们所吹捧的那样吗？
Addiction. 2019 Mar;114(3):401-402. doi: 10.1111/add.14472. Epub 2018 Nov 5.
2
Evaluating dynamic impacts of abuse-deterrent prescription opioid formulations.评估阿片类处方镇痛药滥用威慑剂型的动态影响。
Addiction. 2019 Mar;114(3):400-401. doi: 10.1111/add.14454. Epub 2018 Oct 31.
3
Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting.药品类阿片滥用防御制剂的上市后研究：研究设计和报告框架。
Addiction. 2019 Mar;114(3):389-399. doi: 10.1111/add.14380. Epub 2018 Sep 7.
4
Strategies for Reducing Opioid-Overdose Deaths - Lessons from Canada.减少阿片类药物过量死亡的策略——来自加拿大的经验教训
N Engl J Med. 2018 Apr 26;378(17):1565-1567. doi: 10.1056/NEJMp1800216.
5
Harnessing the language of overdose prevention to advance evidence-based responses to the opioid crisis.利用过量预防的语言，推进以证据为基础的阿片类药物危机应对措施。
Int J Drug Policy. 2018 May;55:77-79. doi: 10.1016/j.drugpo.2018.02.013. Epub 2018 Mar 20.
6
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study.一种具有潜在抗篡改特性的羟考酮制剂对阿片类药物使用及危害的影响：国家阿片类药物滥用威慑（NOMAD）研究的主要发现
Lancet Psychiatry. 2018 Feb;5(2):155-166. doi: 10.1016/S2215-0366(18)30003-8. Epub 2018 Jan 11.
7
Opioid Crisis: No Easy Fix to Its Social and Economic Determinants.阿片类危机：社会经济决定因素难以解决。
Am J Public Health. 2018 Feb;108(2):182-186. doi: 10.2105/AJPH.2017.304187. Epub 2017 Dec 21.
8
The productive techniques and constitutive effects of 'evidence-based policy' and 'consumer participation' discourses in health policy processes.健康政策过程中“循证政策”和“消费者参与”话语的生产技术和构成效应。
Soc Sci Med. 2017 Mar;176:60-68. doi: 10.1016/j.socscimed.2017.01.031. Epub 2017 Jan 22.
9
Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.慢性疼痛中阿片类药物滥用、误用及成瘾率：一项系统评价与数据综合分析
Pain. 2015 Apr;156(4):569-576. doi: 10.1097/01.j.pain.0000460357.01998.f1.
10
Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours.与药物类阿片使用相关的定义：医疗用途以外的使用、转移、不遵医嘱和异常药物相关行为。
Drug Alcohol Rev. 2011 May;30(3):236-45. doi: 10.1111/j.1465-3362.2010.00283.x.
Zotero 插件